Experience in laparoscopic hepatectomy in treatment of hepatocellular carcinoma

Tian Zhou; Zhang JianHuai; Sun XiTai; Liu Bin; Qi FuZhen; Wang YeBo; Wu JinSheng; Gu DianHua

doi:10.3969/j.issn.1001-5256.2018.08.024

Issue 8

Aug. 2018

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2018 > 34(8): 1712-1716

PDF( 220 KB)

Experience in laparoscopic hepatectomy in treatment of hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2018.08.024

Nanjing Medical University

Research funding:

Received Date: 2018-03-01
Published Date: 2018-08-20

Abstract

Abstract

Objective To summarize the clinical experience in laparoscopic hepatectomy in the treatment of hepatocellular carcinoma ( HCC) . Methods The patients with HCC who were admitted to Huaian No. 1 People's Hospital Affiliated to Nanjing Medical University, Drum Tower Hospital Affiliated to Nanjing University, and The Affiliated Hospital of Xuzhou Medical Hospital from December 2008 to December 2015 were enrolled and their clinical data were collected. According to the surgical procedure, these patients were divided into laparoscopic hepatectomy group with 391 patients ( LH group) and open hepatectomy group with 682 patients ( OR group) . The two groups were compared in terms of time of operation, incision size, intraoperative blood loss, postoperative recovery, length of postoperative hospital stay, surgery costs, hospital costs, and complications. The independent samples t-test was used for comparison of continuous data between two groups, and the chi-square test was used for comparison of categorical data between two groups. Results There were significant differences between the LH group and the OR group in intraoperative blood loss ( 165. 00 ± 79. 21 ml vs 457. 00 ± 125. 00 ml, t = 41. 64, P < 0. 05) , length of incision ( 4. 07 ± 0. 31 cm vs 20. 48 ± 2. 36 cm, t = 136. 80, P < 0. 05) , time to diet ( 1. 50 ± 0. 61 d vs 2. 43 ± 0. 40 d, t =30. 10, P < 0. 05) , time to ambulation after surgery ( 1. 36 ± 0. 31 d vs 4. 12 + 0. 82 d, t = 63. 98, P < 0. 05) , length of hospital stay ( 10. 09 ± 3. 52 d vs 15. 36 ± 4. 57 d, t = 19. 70, P < 0. 05) , surgery costs ( 9471. 00 ± 639. 73 yuan vs 5329. 12 ± 461. 40 yuan, t =122. 44, P < 0. 05) , and hospital costs ( 37 315. 17 ± 13 194. 78 yuan vs 35 007. 6 ± 10 611. 20 yuan, t = 3. 13, P < 0. 05) . The 1-, 3-, and 5-year survival rates were 89. 42%, 64. 32%, and 43. 12% in the LH group and 88. 11%, 61. 45%, and 38. 38% in the OR group, and there were no significant differences between the two groups ( P > 0. 05) . Conclusion LH has the advantages of little trauma, low intraoperative blood loss, fast recovery, and short postoperative hospital stay and does not increase complications. Therefore, it can be used as the primary therapy for peripheral liver cancer, small hepatocellular carcinoma, and liver tumor in the left lateral lobe.
- carcinoma, hepatocellular,
- laparoscopy,
- hepatectomy,
- therapeutics

FullText(HTML)

References(13)

References

[1]REICH H, Mc GLYNN F, DECAPRIO J, et al.Laparoscopic excision of benign liver lesions[J].Obstet Gynecol, 1991, 78 (5 Pt2) :956-958.

[2]HUANG DF, ZHANG JH, WU JS, et al.Clinical analyses of laparoscopic hepatectomy for liver neoplasms:A report of 21 cases[J].Chin J Gen Pract, 2013, 12 (7) :574-576. (in Chinese) 黄东方, 张建淮, 吴金声, 等.腹腔镜肝肿瘤切除术21例临床分析[J].中华全科医师杂志, 2013, 12 (7) :574-576.

[3]HUANG MS, SUN XT, LI Q, et al.Anatomical observation and discussion on technical points of laparoscopic resection of left liver[J].J Hepatobiliary Surg, 2013, 21 (1) :18-21. (in Chinese) 黄茂盛, 孙喜太, 李强, 等.腹腔镜左半肝切除的解剖学观察及技术要点探讨[J].肝胆外科杂志, 2013, 21 (1) :18-21.

[4]WU D, WU W, LI Y, et al.Laparoscopic hepatectomy for colorectal liver metastases located in all segments of the liver[J].J BUON, 2017, 22 (4) :856-862.

[5]MARTINEZ-CECILIA D, FONTANA M, SIDDIQI NN, et al.Laparoscopic parenchymal sparing resections in segment 8:Techniques for a demanding and infrequent procedure[J].Surg Endosc, 2018, 32 (4) :2012-2019.

[6]WANG YH, LIU R, ZHOU NX, et al.Laparoscopic liver resection:Report of 16 cases[J].Chin J Min Inv Surg, 2003, 3 (6) :473-475. (in Chinese) 王悦华, 刘荣, 周宁新, 等.腹腔镜肝切除16例临床分析[J].中国微创外科杂志, 2003, 3 (6) :473-475.

[7]ZHOU B, WANG ZW, NIU J, et al.Short-term efficacy of laparoscopic versus open liver resection for small hepatocellular carcinoma[J].Chin J Gen Surg, 2013, 22 (7) :862-866. (in Chinese) 周兵, 汪正伟, 牛坚, 等.腹腔镜与开放性肝切除术治疗小肝癌的近期疗效比较[J].中国普通外科杂志, 2013, 22 (7) :862-866.

[8]XU G, QI FZ, ZHANG JH, et al.Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinoma[J].World J Surg Oncol, 2012, 10:163.

[9]NIU J, WANG HJ, SHAO H, et al.Clinical control study on postoperative clinical rehabilitation index and immune effects of laparoscopic resection of hepatocellular carcinoma (HCC) [J/CD].Chin J Laparoscopic Surgery:Electronic Edition, 2014, 7 (3) :199-204. (in Chinese) 牛坚, 汪海军, 邵华, 等.腹腔镜肝癌切除术对术后机体康复和免疫的影响研究[J/CD].中华腔镜外科杂志:电子版, 2014, 7 (3) :199-204.

[10]NIU J, WANG HJ, SHAO H, et al.Clinical control study on effects of postoperative clinical rehabilitation index and humoral immune of laparoscopic resection for liver cancer[J].Chin J Bases Clin Gen Surg, 2013, 20 (4) :356-361. (in Chinese) 牛坚, 汪海军, 邵华, 等.腹腔镜肝癌切除术对患者术后临床康复和体液免疫影响的临床对照研究[J].中国普外基础与临床杂志, 2013, 20 (4) :356-361.

[11]XU JB, QI FZ, XU G, et al.Comparison of the efficacy of radiofrequency ablation and surgical resection for the treatment of small primary hepatocellular carcinoma[J].Mod Oncol, 2013, 21 (8) :1822-1825. (in Chinese) 徐建波, 祁付珍, 许刚, 等.原发性中小肝癌手术与射频消融治疗的疗效分析[J].现代肿瘤医学, 2013, 21 (8) :1822-1825.

[12]WEI X, LIU B, WANG FT.Total laparoscopic hepatectomy:A clinical analysis of 17 cases[J].Mod J Integr Tradit Chin West Med, 2014, 23 (7) :759-760. (in Chinese) 魏鑫, 刘斌, 王飞通.完全腹腔镜下肝切除17例临床分析[J].现代中西医结合杂志, 2014, 23 (7) :759-760.

[13]INOUE Y, SUZUKI Y, FUJII K, et al.Laparoscopic hepatic resection using extracorporeal pringle maneuver[J].J Laparoendosc Adv Surg Tech A, 2018, 28 (4) :452-458.

Relative Articles

[1]	Xuehai YU, Bendong CHEN, Yimin LIU, Yongxin MA, Xusheng ZHANG, Hongcai ZHOU, Haiyan MA. Role of NOD-like receptor protein 3 inflammasome in the development and progression of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2024, 40(2): 397-401. doi: 10.12449/JCH240229
[2]	Yijie ZHAO, Lu XIE, Yating ZHANG, Guangwei LIU. Pyroptosis： A new bridge connecting gut microbiota and liver diseases[J]. Journal of Clinical Hepatology, 2024, 40(9): 1908-1915. doi: 10.12449/JCH240930
[3]	Xuelian GU, Junfeng LI, Xiaorong MAO. Research advances in nonalcoholic fatty liver disease-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(1): 196-200. doi: 10.3969/j.issn.1001-5256.2022.01.034
[4]	Minghao LIU, Sutong LIU, Dongfang SHANG, Lihui ZHANG, Yajiao GU, Wenxia ZHAO. Effect of Huatan Qushi Huoxue prescription on lipopolysaccharide-induced pyroptosis of macrophages[J]. Journal of Clinical Hepatology, 2022, 38(9): 2016-2019. doi: 10.3969/j.issn.1001-5256.2022.09.014
[5]	Juan WANG, Yingchun WANG, Chunyu WANG. Association between monocyte-to-high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(5): 1137-1141. doi: 10.3969/j.issn.1001-5256.2021.05.031
[6]	Yalan LEI, Jian BI, Jingwei MAO. Impact of nonalcoholic fatty liver disease on intestinal immune cells[J]. Journal of Clinical Hepatology, 2021, 37(11): 2667-2671. doi: 10.3969/j.issn.1001-5256.2021.11.039
[7]	Shiyan YAN, Jiangao FAN. Diagnosis and treatment of hepatocellular carcinoma associated with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(8): 1748-1752. doi: 10.3969/j.issn.1001-5256.2021.08.002
[8]	Xinyue WANG, Deguan LI. Mechanism of pyroptosis and its role in the development and progression of liver diseases[J]. Journal of Clinical Hepatology, 2021, 37(12): 2976-2980. doi: 10.3969/j.issn.1001-5256.2021.12.051
[9]	YANG Jing, GAO Hong, ZHAO YaoWei, WANG Rui. Role of liver sinusoidal endothelial cells in the pathogenesis of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(11): 2601-2605. doi: 10.3969/j.issn.1001-5256.2020.11.046
[10]	Jiang Zhao, Ruan Bo. The role of liver sinusoidal endothelial cells in the progression of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(3): 684-686. doi: 10.3969/j.issn.1001-5256.2020.03.047
[11]	Zhang YongChao, Li Wei. Association between diabetes and nonalcoholic fatty liver disease-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2020, 36(10): 2329-2332. doi: 10.3969/j.issn.1001-5256.2020.10.037
[12]	Luo YuXin, Guo JinBo, Zhang XiaoLan. Research advances in the role of macrophages in nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(3): 680-683. doi: 10.3969/j.issn.1001-5256.2020.03.046
[13]	Luo Yan, Shi JunPing. Research advances in the pathogenesis of nonalcoholic fatty liver disease-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2020, 36(6): 1217-1220. doi: 10.3969/j.issn.1001-5256.2020.06.005
[14]	Fan Chang, Wu FuRong, Zhang JiaFu, Jiang Hui. Role of pyroptosis in the pathogenesis of hepatic fibrosis[J]. Journal of Clinical Hepatology, 2020, 36(5): 1138-1140. doi: 10.3969/j.issn.1001-5256.2020.05.042
[15]	Wei BiWei, Gong YaHui, Liang ZhiHai. Role of pyroptosis in the pathogenesis of acute pancreatitis[J]. Journal of Clinical Hepatology, 2020, 36(8): 1905-1908. doi: 10.3969/j.issn.1001-5256.2020.08.050
[16]	XIAO WeiSong, LE YingYu, ZENG ShengLan, TAN XiaoBin, WU Cong, YA ChengYu, MAO DeWen. Role of pyroptosis in liver diseases[J]. Journal of Clinical Hepatology, 2020, 36(12): 2847-2850. doi: 10.3969/j.issn.1001-5256.2020.12.044
[17]	Zhou ZhenHua, Wang LingTai, Gao YueQiu. Role of hepatocyte mitophagy in the pathogenesis of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2019, 35(12): 2809-2811. doi: 10.3969/j.issn.1001-5256.2019.12.036
[18]	Liu SuTong, Zhao WenXia. Research advances in the pathogenesis of nonalcoholic fatty liver disease-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2019, 35(7): 1621-1625. doi: 10.3969/j.issn.1001-5256.2019.07.043
[19]	Ye QianLing, Mao DeWen, Wang MingGang, Wang Na. Role of NLRP3 inflammasome in the development and progression of liver diseases[J]. Journal of Clinical Hepatology, 2019, 35(10): 2346-2350. doi: 10.3969/j.issn.1001-5256.2019.10.048
[20]	Gui WenFang, Zhu QingJing, Yang Ling. Research advances in nonalcoholic fatty liver disease-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(12): 2693-2697. doi: 10.3969/j.issn.1001-5256.2018.12.040

Supplements(0)

Cited By

Cited by

Periodical cited type(1)

徐大洲，张树贤，王坤，左晨艳，曾毅，袁青文，张志梅. 血清簇集蛋白、1-磷酸鞘氨醇水平对脓毒症急性肝损伤患者的预后价值. 临床肝胆病杂志. 2023(12): 2867-2872 .

本站查看

Other cited types(3)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (419) PDF downloads(68)

Experience in laparoscopic hepatectomy in treatment of hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2018.08.024